AmCham Singapore Healthcare Conference: Agile Collaboration to Revolutionize Healthcare

Event Details

Building on the momentum of our inaugural conference, AmCham is pleased to host the return of the AmCham Healthcare Conference with the theme "Agile Collaboration to Revolutionize Healthcare". Graced by Professor Ivy Ng, Senior Advisor of SingHealth Board, the conference will explore the power of collaboration to transform healthcare delivery.

Singapore's vision for the future of healthcare prioritizes supporting an ageing population, expanding clinical services, and leveraging technology like Artificial Intelligence (AI) and telehealth. To achieve this vision, agile collaboration across healthcare stakeholders is crucial. This conference is an opportunity to bring together policymakers, providers, payors, patients, and other key stakeholders to explore new areas of collaboration and innovation to revolutionize healthcare and improve patient outcomes.

For sponsorship opportunities, please contact Lee-Mey Goh, Senior Director, Strategic Partnerships & Development.

*Lunch will be provided.

Please note the following details:

The event is held under the Chatham House Rule https://www.chathamhouse.org/about-us/chatham-house-rule
Images from the event may be used for AmCham Singapore's post-event information, marketing and promotional purposes.
The personal information provided to us will only be used for event registration and administration.

By registering for this event, you agree and consent to the above.

* For any enquires please contact the AmCham Programming and Events Team at pe@amcham.com.sg.

* Cancellation Policy: You may request to cancel your registration 5 working days or more prior to the event date. Full payment will be required for any cancellations or no shows thereafter. Replacements will be accepted.

Kindly make payment for your ticket upon confirmation of your registration. By paying for your ticket before the event, you help make sure that AmCham can continue to offer meaningful programming for our members.

Agenda

June 5, 2024

Main Schedule

9:30 AM - 10:00 AM

General Registration

10:00 AM - 10:05 AM

Welcome Remarks by AmCham Singapore

10:05 AM - 10:10 AM

Opening Remarks

10:10 AM - 10:15 AM

Introduction of Prof. Ivy Ng, Senior Advisor of SingHealth Board

10:15 AM - 10:30 AM

Keynote #1: Prof. Ivy Ng, Senior Advisor of SingHealth Board

Professor Ivy NG

10:30 AM - 11:00 AM

Fireside Chat with Prof. Ivy Ng and Anjali Bhat, Country Manager, Singapore at Cochlear

Professor Ivy NG

Anjali Bhat

11:00 AM - 11:30 AM

Morning Break

11:30 AM - 12:15 PM

Panel #1: Revolutionizing Healthcare Through AI

Technological advancements, such as Artificial Intelligence (AI), are rapidly transforming the healthcare landscape by helping to improve diagnostic efficiency and accuracy, accelerate drug development, customize treatments, provide patient self-management tools and streamline care delivery. More importantly, with the right tools, healthcare professionals and patients can enjoy a deeper, more holistic relationship on the human level, free from administrative burdens, communication issues and logistical obstacles.

This panel will explore how the public and private healthcare sectors are leveraging AI solutions to revolutionize care and improve patient outcomes.

Anwar Rafique, PBM

Andy Ta

Ying Ying Yeoh

Dr Sebastian Maurer-Stroh

Main Schedule (Continuation)

12:15 PM - 1:00 PM

Panel #2: HealthierSG – Innovations in Preventative Care and Chronic Disease Management

Achieving the holy grail of preventive care will require new ways of thinking and new technologies to shift from a reactive treatment approach to proactive prevention of disease. The Healthier SG plan was introduced to deliver preventive and holistic care for Singapore’s aging population cost-effectively, efficiently, and accessibly. Innovations along the care pathway are needed to power health reforms that address the differing needs of healthcare providers, patients, providers, and payers. For example, national health programs are leveraging mobile apps and wearable technology to track healthy habits, encourage ownership of health, and create supportive communities while generating data that inform the iterative process to develop effective interventions.

This panel will explore the role of innovations in preventive care and chronic disease management and how innovations can be implemented and scaled.

Assoc Prof Su-Yen Goh

Dr. Foong Tsin Uin

Dr. Shailendra Bajpai

1:00 PM - 2:00 PM

Lunch

2:00 PM - 2:05 PM

Introduction of Keynote Speaker #2 Dr. Keith Lim, Group Head of Medical and Quality, IHH Healthcare

2:05 PM - 2:25 PM

Keynote #2: Dr. Keith Lim, Group Head of Medical and Quality, IHH Healthcare

A/Prof Keith Lim

2:25 PM - 3:10 PM

Panel #3: Appropriate and Value-Based Care – Improving Health Outcomes by Measuring Impact and Taking Action.

The implementation of value-based care models is critical as Singapore increases its focus on preventive health and managing costs. However, moving from a fee-for-service model to outcome-driven care requires well-designed, standardized measurement tools, highly integrated data systems and thoughtful change management. One of the biggest challenges will be to collect and analyze a high volume of data in order to generate actionable insights for improved patient care and health outcomes.

This panel will dive into the intricacies of implementing appropriate and value-based care within Singapore’s healthcare system – optimizing processes to shape policies that deliver higher quality, efficient and sustainable care and generate value for patients.

Professor John Abisheganaden

Dr. Phyllis Kim

A/Prof Keith Lim

Ivan Tan

Dr. Yoong Siew Lee

3:10 PM - 3:15 PM

Closing Remarks

3:15 PM - 3:30 PM

Afternoon Break + Networking

Workshop #1

3:30 PM - 5:00 PM

Harnessing the Potential of Digital Technology and AI -- Opportunities for Agile Collaboration

Following the insightful keynotes and panel discussions, this workshop aims to bridge the gap between theory and action. We’re bringing together participants from the public and private sector and academia to discuss the key barriers and challenges in developing, adopting, and implementing digital technology and AI in healthcare. Through group discussions, attendees will discuss and define challenge statements for further action following the conference.

A/Prof. Henry Ho

Professor Dean Ho

5:00 PM - 5:30 PM

Networking

Workshop #2

3:30 PM - 5:00 PM

Building Healthier Communities – Leveraging the Expertise of Industry Partners

Following the insightful keynotes and panel discussions, this workshop aims to bridge the gap between theory and action. We’re bringing together participants from the public and private sector and academia to discuss the key barriers and challenges in engaging different stakeholders and leveraging their knowledge and expertise to build healthier communities. Through group discussions, attendees will discuss and define challenge statements for further action following the conference.

Professor David B. Matchar

5:00 PM - 5:30 PM

Networking

Workshop #3

3:30 PM - 5:00 PM

Unlocking Value through Public-Private Partnerships – The Promise of Value-Based Healthcare

Following the insightful keynotes and panel discussions, this workshop aims to bridge the gap between theory and action. We’re bringing together participants from the public and private sector and academia to discuss the key barriers and challenges in shaping public-private partnerships that can unlock a successful value-based healthcare (VBHC) model. Through group discussions, attendees will discuss and define challenge statements for further action following the conference.

Shikha Kumari

Benjamin Ong Shao Kiat

5:00 PM - 5:30 PM

Networking

No Workshop

3:30 PM - 5:00 PM

Free & Easy

For attendees who choose not to attend any of the workshops.

5:00 PM - 5:30 PM

Networking

Speakers

Professor Ivy NG

Senior Advisor at Singapore Health Services Pte Ltd (SingHealth) Board

Professor John Abisheganaden

Director and Senior Consultant; Health Services & Outcomes Research of National Healthcare Group

Dr. Shailendra Bajpai

Medical & Public Affairs Director - Asia of embecta

Anjali Bhat

Country Manager, Singapore at Cochlear

Assoc Prof Su-Yen Goh

Head at SingHealth Duke-NUS Diabetes Centre and Clinical Director, Future Health Systems

A/Prof. Henry Ho

Executive Director of National Health Innovation Centre

Professor Dean Ho

Head, Department of Biomedical Engineering at National University of Singapore

Dr. Phyllis Kim

Head of the Evidence to Practice Office (ETPO) at Agency for Care Effectiveness (ACE)

Shikha Kumari

Deputy Director, Value Driven Outcomes (VDO) Office of NUHS

A/Prof Keith Lim

Group Head of Medical and Quality at IHH Healthcare

Professor David B. Matchar

Professor, Health Services and Systems Research (HSSR) at Duke-NUS Medical School

Dr Sebastian Maurer-Stroh

Executive Director of A*STAR Bioinformatics Institute (BII)

Benjamin Ong Shao Kiat

Senior Principal Lead Specialist (Health Technology Evaluation, Utilisation Review & Adoption) at Agency for Care Effectiveness, Ministry of Health, Singapore

Anwar Rafique, PBM

CEO & Co-Founder of MyCLNQ Health

Dr. Yoong Siew Lee

Medical Advisor at Income Insurance Ltd

Andy Ta

Director, Data aNalytics & AI (DNA) & Chief Data Officer of Synapxe Pte. Ltd.

Ivan Tan

Healthcare Access Solutions Lead, SEA & India at Johnson & Johnson Innovative Medicine

Dr. Foong Tsin Uin

Co-Founder & Chief Medical Officer of Osler Health

Ying Ying Yeoh

General Manager at Roche Pharmaceuticals, Singapore

Professor Ivy Ng is Senior Advisor, SingHealth Board. Prior to her appointment as Senior Advisor, she was the Group Chief Executive Officer of SingHealth (2012-2024). She was also previously Chief Executive Officer of KK Women's & Children's Hospital (KKH) and Deputy Group Chief Executive Officer of SingHealth.

SingHealth is Singapore’s largest healthcare group and comprises Singapore General Hospital, KK Women’s and Children’s Hospital, Changi General Hospital, Sengkang General Hospital, 5 National Specialty Centres (Cancer, Eye, Neurosciences, Dental and Heart), SingHealth Community Hospitals and 9 primary health polyclinics. SingHealth has also been charged to develop Eastern General Hospital.

She was conferred the Singapore Human Resource Institute Leading CEO Award 2008, the International Management Action Award 2010, the Public Administration Medal (Gold) 2011, Her World Woman of the Year 2012, NTUC May Day Medal of Commendation (Gold) Award 2020, NUS University Outstanding Service Award 2020 and President’s Science & Technology Medal 2021. She is member of the Boards of Duke-NUS Medical School, Singapore Management University and Temasek Trust Ltd.

She holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) and Master of Medicine (Paediatrics) from the National University of Singapore. She is a Fellow of the Royal College of Physicians (FRCP, Edinburgh), Royal College of Paediatrics and Child Health (FRCPCH, London) and Academy of Medicine, Singapore (FAMS). She is Clinical Professor, Duke-NUS Medical School and Yong Loo Lin School of Medicine, National University of Singapore and Adjunct Professor, Saw Swee Hock School of Public Health.

Adjunct Professor John Abisheganaden is Director and Senior Consultant at Health Services and Outcomes Research (HSOR), National Healthcare Group (NHG). He is also a Senior Consultant at the Department of Respiratory & Critical Care Medicine, Tan Tock Seng Hospital. He holds a Fellowship from the Royal College of Physicians, Edinburgh UK; a Master of Medicine (Internal Medicine) from NUS Singapore, as well as a Fellow of the Academy of Medicine (Respiratory Med) from the Academy of Medicine Singapore. He leads his team in population decision analytics and operations research, implementation and outcomes evaluation, as well as health system performance and sustainability. He is the lead clinician of the NHG Value Based Care team. He is also chair of the NHG Respiratory Health Steering Committee.

Dr. Shailendra Bajpai is a specialist physician trained in Internal Medicine, Diabetes & Endocrinology with over 30 yrs. of experience in clinical practice, public health, biopharmaceuticals and health technology. He is currently the Medical & Public Affairs Director- Asia for embecta (formerly Becton Dickinson Diabetes Care), based at Singapore. He had his medical education and trainings at renowned academic institutions and international COEs including the All India Institute of Medical Science, International Diabetes Center, Minneapolis, USA, by the American Diabetes Association and by Vienna School of Clinical Research.

Dr. Bajpai is passionate about improving the lives of people with Diabetes and their loved ones. He has established several PPPs in developing countries, including Asia with the objective of enhancing knowledge & skills of the providers, creating advocacy, improving access, and uplifting the standards of care through multi-stakeholder healthcare ecosystems.

Dr. Bajpai has been involved as a clinical research physician and medical advisor in the development programs of Air Insulin, incretin mimetics, certolizumab pegol, rotigotine and with the launch of first in class incretin mimetic- exenatide(Byetta), lixisenatide (Lyxumia), insulin analogues (Insulin Lispro, Insulin IGlar U300), GLP-1 agonists & Insulin combinations (Soliqua) as well as several other drugs in cardio-metabolic and neuropsychiatry therapeutic areas. He has also worked on Digital health and Medical technology solutions in Diabetes and CV- metabolic space. He has authored several original research articles in peer reviewed international scientific journals and is on the editorial board of journals of repute.

He is an SME, a speaker & author on health and wellness topics for diverse audiences including public, patients, providers and policy makers. He has founded and works closely with Non-profits in education, health and wellness and in the social impact sector. He has recently been featured in the book ‘A dose of inspiration’ - 100 purpose stories from pharma leaders . His work includes education on living well with diabetes, management of Diabetes, & health and wellbeing with a holistic perspective. He firmly believes that community and peer support, patient empowerment, awareness, education and advocacy with the proper use of technology can move the needle for prevention, diagnosis, and better management of Diabetes and other chronic diseases. He contributes to the integrated care, health tech & med tech ecosystem as a SME mentor. He is also a meditation and mindfulness practitioner and coach.

Anjali Bhat is the Country Manager for Cochlear (Singapore). An audiologist by education, she has been part of Cochlear implant industry in technical and leadership roles for the last 9 + years working with patients, families, audiologists, rehabilitationists and ENT surgeons in India and in SEA.

As part of her career development, she was a part of AmCham Next Gen Business Leadership 2021 batch, when she embarked on a business and people leadership role in Singapore.

She obtained her Doctor of Audiology in Aug 2021 from Salus University, Pennsylvania.

As a formally trained Indian Classical music vocalist, she continues to learn music till date since the age of 4. In her free time, she is passionate about travel, community work and hearing health initiatives.

Henry HO is the Chairman for Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore; Academic Chair for Surgery Academic Clinical Program, SingHealth. Currently A/Prof Henry is also holding the appointment as Director for SingHealth Duke-NUS Innovation Centre.

A/Prof Henry is a urological surgeon that specializes in robotic surgery for urological cancers such as prostate & kidney. He received his MBBS and Master of Medicine (Surgery) from the National University of Singapore. After his accreditation as a Urologist, he further specializes with fellowships in robotic surgery in University of Innsbruck, Austria and Stone surgery in Hamburg, Germany.

A/Prof Henry is an advocate for innovation in his clinical career. He is an early adopter of new technology with robust scientific methodology. Amongst his many publications, the randomized control trial on bipolar technology for prostate enlargement changes the practice of urologist internationally.

He went on to be an innovator with the invention of Mona LisaTM transperineal prostate biopsy device (Biobot Surgicals Pte Ltd). He brought this project from a research project to commercial company. The device provide safe and accurate diagnosis of prostate cancer in men. It is used in many Singapore hospitals, Germany, Australia and China.

A/Prof Henry also contributes to the Singapore innovation ecosystem. He was the first doctor in SGH/SingHealth to be awarded the Singapore-Stanford Biodesign Fellowship Award by A*STAR in 2011. He started the Medical technology Office (MTO) in Singhealth to help more clinicians onto this innovation journey. Its goal is to nurture doctors, nurses and allied health with grants and technology matching to become clinician-innovators. His NMRC is Co-chair of the Clinician-innovator taskforce and Chair for clinician-innovator development grant.

A/Prof Henry leads the clinical test-bedding and adoption in Singhealth-DUKE NUS Academic Medicine Innovation Institute which aims to facilitate implementation of technologies with external partners into the healthcare system. to imbue such vibrant exchange and collaboration (Digital, technologyand process), there will be a healthcare Innovation and transformation center.

Professor Dean Ho is currently Provost’s Chair Professor, Director of The Institute for Digital Medicine (WisDM) at the Yong Loo Lin School of Medicine; Director of The N.1 Institute for Health (N.1), and Head of the Department of Biomedical Engineering at the National University of Singapore (NUS).

Prof. Ho and collaborators manage a portfolio of over 10 prospective, interventional human clinical trials. His team successfully developed and validated CURATE.AI, a powerful artificial intelligence platform that personalizes human treatment for a broad spectrum of indications ranging from oncology, to digital therapeutics and infectious diseases, among others. His team also developed IDentif.AI to optimise combination therapy design against SARS-CoV-2 and to address antimicrobial resistance.

Prof. Ho is an elected Fellow of the US National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. He was also named to the HIMSS Future50 Class of 2021 for his internationally-recognised leadership in digital health. Prof. Ho is also a Subgroup Lead in the World Health Organization (WHO) Working Group for the regulation of AI for Health, which was recently released globally.

Prof. Ho is an author of the best-selling book, Medicine Without Meds, which has released internationally. The book serves as a blueprint for a broad community – from business leaders and venture capitalists to healthcare systems – on how to accelerate practice-changing innovation to patients and caregivers. All author proceeds from the book will be benefiting the WisDM Patient Impact Fund at NUS.

In popular and international media, Prof. Ho has appeared on the National Geographic Channel Program “Known Universe,” and Channel News Asia’s “The Hidden Layer: Healthcare Trailblazers". His discoveries have been featured on CNN, The Economist, Straits Times, National Geographic, Forbes, Washington Post, NPR and other international news outlets.

Prof. Ho is a recipient of the Tech Heroes from Crisis Pathfinder Award from the Singapore Computer Society, NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. He has also served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a leading global drug development organization.

Phyllis is a medical doctor by training with a specialist certification in Public Health, and is the Head of the Evidence to Practice Office (ETPO) in the Agency for Care Effectiveness (ACE), MOH since May 2022. In this role, Phyllis leads the team in developing evidence-based ACE Clinical Guidances (ACGs) for local clinicians and healthcare professionals; and in the planning and implementation of programs to influence clinical practice changes that improve patient outcomes. Prior to this, Phyllis and diverse roles in other MOH divisions, and included shaping national-level health policies, such as in non-communicable diseases strategy, undergraduate and postgraduate curriculum, and development of new hospitals’ care models and services planning. In earlier years, Phyllis worked in in NHS UK in various clinical postings, including medical rotations in Wolverhampton; and Emergency Medicine in Addenbrookes NHS Foundation Trust and Salford Royal, Manchester.

Shikha Kumari is a highly accomplished healthcare professional currently serving as the Deputy Director of the Academic Informatics Office at the National University of Health System (NUHS). With over 20 years of experience in the field, she has established herself as an expert in Value Based Healthcare, Health Informatics, Quality Improvement, Electronic Medical Record, and Process re-engineering.

Within NUHS, Shikha is responsible for overseeing the highly regarded Value Driven Outcome (VDO) Programme, which has received numerous accolades. This program focuses on assessing the value of care by measuring both the quality and cost of healthcare services. In addition to her managerial role, Shikha is actively engaged in teaching as an Adjunct Instructor at the National University of Singapore. She also contributes her expertise as a member of the Health Informatics Pathway Programme Committee at the Yong Loo Lin School of Medicine, where she runs the Value-based healthcare module for the Department of Biomedical Informatics.

Prior to her current position, Shikha gained extensive experience working with renowned firms, including big 4 and fortune 500 companies, which further enhanced her knowledge and skills in the industry.

Shikha holds a Master of Business Administration (MBA) degree from the Asian Institute of Management in Manila, Philippines, and a Bachelor of Engineering (BE) degree from PESIT in Bangalore, India.

Associate Professor Keith Lim currently serves as the Group Head of Medical and Quality at IHH Healthcare, a leading healthcare organization that owns and operates 80 over hospitals across Asia and Europe. In this role, he oversees all aspects of clinical quality, patient safety and value-based care within the group. His responsibilities include designing and implementing policies and quality improvement efforts to ensure that patients receive effective and safe care.

With over 20 years of clinical experience as a radiation oncologist, Prof Lim has made significant contributions to academia. He previously served as the Assistant Dean of the NUS School of Medicine. His research work has been cited over 1500 times, and he has been awarded over 2.5 million dollars in competitive research grant funding.

A/Prof Lim pioneered the value-based healthcare program in Singapore while working at the NUHS healthcare cluster as the Group Chief Value Officer. Under his guidance, NUHS became the first healthcare cluster to demonstrate the ability to use clinical and financial data to drive value. This was achieved by improving clinical outcomes while reducing waste. His achievements were recognized with the National Medical Excellence Award, the highest medical honor in Singapore.

During his tenure at the Ministry of Health, Singapore, A/Prof Lim served as the director in charge of clinical outcomes and value. In this capacity, he was responsible for setting the standards of clinical care in the Singapore healthcare system and implementing value-driven care across all Singapore public hospitals.

Since joining IHH, A/Prof Lim has supervised clinical units to ensure that clinical performance and safety standards meet world-class levels. He has also expanded the scope and coverage of IHH's value-driven outcomes initiatives to all its geographies, aiming to provide excellent outcomes and cost-effective care to more patients globally.

Professor David Bruce Matchar is the Inaugural Director of the programme in Health Services and Systems Research (HSSR) (2008-2018) at Duke-NUS. He is also Professor of Medicine at Duke University in the United States. He currently serves as lead economic and policy analyst to the Singapore clinical genomics program, PRECISE, and consultant to the Ministry of Health national initiative for healthcare transformation, Healthier SG.

Prof Matchar has worked in clinical research for over 35 years; his work primarily relates to stroke and other chronically disabling neurological disorders, as well as clinical and public policy analysis. He served as Director of the Duke Center for Clinical Health Policy Research and established the Duke Evidence-based Practice Center, which was responsible for analysis in support of coverage policy for the US Centers for Medicare and Medicaid Services, as well as guidelines for medical professional societies.

While the content of Professor Matchar’s research spans the range of clinical medicine, the essential nature of his work has involved integration of researchers from multiple disciplines under a common conceptual framework, to address important and complex healthcare issues. His overarching goal has been to promote the use of best evidence to support clinical and public policy decision making. A fundamental challenge is how to bridge the gap between analysts and decision makers—a challenge made more difficult when the issues involve multiple stakeholders, competing priorities, and are complex in detail and dynamics.

More recently, Prof Matchar has applied simulation modeling to clarify the challenges of a rapidly aging population, including future prevalence of disability and the impact of education the trajectory of prevalence, understanding the role of different forms of long-term care services in alleviating caregiver burden, and estimating health care manpower requirements under alternative models of care. This work has led to the formulation of a needs-based framework for healthcare delivery and the development, validation and application of the Simple Segmentation Tool (SST), a simplified inventory of patient-level health service needs, different combinations of which can be mapped to different appropriate means for addressing these needs. He has extended this effort from developed countries (US, Singapore, and Switzerland) to low/middle income countries (Cambodia, Thailand).

Dr Sebastian Maurer-Stroh studied theoretical biochemistry at the University of Vienna and wrote his master and PhD thesis at the Institute of Molecular Pathology (IMP). After FEBS and Marie Curie fellowships at the VIB-SWITCH lab in Brussels, he has been leading a group of experts in protein sequence analysis as a senior principal investigator in the A*STAR Bioinformatics Institute (BII) since 2007. He is Executive Director of A*STAR’s BII since January 2021. His protein function analysis skills are supporting A*STAR’s efforts at the public-private interface and through computational analysis and modelling, his team is critically contributing to national and global viral pathogen surveillance. He is also adjunct Professor at the National University of Singapore (NUS) and an infectious disease expert for A*STAR ID Labs and the National Public Health Laboratory of the Ministry of Health, Singapore.

Benjamin is a Senior Principal Lead Specialist at the Agency for Care Effectiveness (Singapore). He oversees the Economic Modelling and Outcomes Evaluation team which performs economic evaluations to support health technology assessments (HTA) for funding decisions, and tracks utilisation and outcomes related to health technologies to study the impact of funding decisions. He also oversees the Guidance Adoption team that is responsible for driving the adoption and uptake of cost-effective drugs and medical technologies in the public healthcare institutions. Benjamin began his career as a pharmacist at the National University Hospital Singapore and served as a deputy director at the Health Sciences Authority prior to joining ACE.

A HealthTech entrepreneur and former seasoned banker, brings forth a wealth of experience spanning two decades in banking and financial services. With a vision centered on Empowering Digital Health for the community's well-being and deeply committed to giving back through grassroots leadership and active engagement in volunteer services.

He has received a prestigious national Public service medal from Singapore Government Pingat Bakti Masyarakat[PBM] for extra ordinary work during COVID-19 pandemic crisis.

Anwar believe in giving back to the community and is a grassroots leader engaged in volunteer services. He is fascinated with all new technology like AR/VR, AI & Machine Learning and how this can be used to make more efficient and affordable digital healthcare service to the community. Before starting his entrepreneurial journey, Anwar was heading strategy & risk team with top tier bank in Singapore.

Dr Yoong is currently the Medical Advisor at Income Insurance Ltd where she supports health and medical related functions. She is also the Convenor of the Life Insurance Association (LIA) health subcommittee since 2022 and has served as the LIA representative at the MOH Fee Benchmark Committee.
Dr Yoong trained as a paediatrician before moving on to roles in hospital and healthcare administration in the public sector in Singapore. She has extensive experience in areas of hospital operations including clinical services, allied health professional services, clinical quality, and medico-legal and risk management issues. During her time at public hospitals as well as with a Consulting firm, she was involved in systems implementation of IT projects such as pharmacy automation and electronic health records.

Andy is responsible for the visioning, planning and implementation of system-wide and institution-level data, analytical & AI capabilities/ programmes across the care continuum for effective enablement of analytics and data science across public health organisations in alignment to Ministry of Health’s Healthcare Masterplan.

Andy’s efforts include building a strong AI & data science community in healthcare, encouraging collaborations among public health institutions to implement innovative or transformative approaches to healthcare services, patient care delivery and population health through use of big data and advanced analytics.

Andy has published six papers, including “Development and Implementation of Nationwide Predictive Model for Admission Prevention” paper publication by IEEE Engineering in Medicine and Biology Society (EMBS) in March 2018.

Ivan Tan is a global healthcare leader with over 15 years of experience, and with the past 8 years in Johnson & Johnson’s (J&J) pharmaceutical business. He has built a rich and diverse set of experiences spanning pharmaceutical market access, reimbursement and pricing, business insights, and healthcare consulting across stints in Switzerland, the US (New Jersey), and Singapore.

He has led teams on developing the pricing and reimbursement strategies across J&J’s pharmaceutical portfolio across disease areas such as Multiple Myeloma, B-cell Lymphoma, Prostate Cancer, Immunology, and Mental Health – both at the Asia Pacific level and at the corporate global level.

As part of his 5-year stint at J&J’s pharmaceutical headquarters in the US, he built & led J&J’s global COVID-19 vaccine allocation team, developed and executed the global allocation principles that determined country-level access to the J&J vaccine during the pandemic. His other achievements include spearheading the global pricing and payment model strategy for both J&J’s first hemato-oncology CAR-T and retinal gene therapy.

Prior to his time at J&J, he also has had extensive experience in healthcare insights generation and consulting, which included leading teams in Basel, Switzerland for a multinational healthcare research and consulting company over a 5-year period. He is known to be a strategic thinker with a global perspective, adept at navigating complex environments, and driving impactful outcomes in the healthcare industry.

A born and bred Singaporean who has worked with multinational, cross-cultural teams throughout his time living/working across three different continents, he is glad to be back home, exploring different healthcare access solutions for patients in SEA and India.

After two decades of experience as a family physician in both the UK and Singapore, Dr Foong co-founded Osler Health in 2020. Her vision was to deliver bespoke healthcare at the highest level – both in the realm of medical knowledge and service standards.

Dr Foong is an active practising Primary Care clinician whilst also managing the medical and business aspects of running a successful medical practice. This has allowed her to keep constantly updated and abreast of clinical knowledge and changes within the medical field and to lead and shape the gold-standard practice of primary care services, where chronic disease management and preventive health are key components. Dr Foong brings science-back, evidence-based medical care to Osler Health, whilst harnessing digital healthcare and AI-driven methods with conventional healthcare practices. As a founding member of the Singaporean Lifestyle Medicine Society, Dr Foong is a proponent of lifestyle medicine practices which underpin the fundamental approaches in one’s preventive health journey.